Abstract is: Montserrat García-Closas, M.D., M.P.H., Dr.P.H., is a Spanish researcher and academic who is best known for her works on identifying cancer biomarkers and genetic susceptibility to cancer. Dr. García-Closas serves as the deputy director of the Division of Cancer Epidemiology & Genetics (DCEG) of the National Cancer Institute, as well as the Acting Chief of the Integrative Tumor Epidemiology Branch of the DCEG.
| human | Q5 |
| P227 | GND ID | 1228447276 |
| P2671 | Google Knowledge Graph ID | /g/11qp2_h323 |
| P496 | ORCID iD | 0000-0003-1033-2650 |
| P1053 | ResearcherID | F-3871-2015 |
| P214 | VIAF ID | 53633398 |
| P27 | country of citizenship | Spain | Q29 |
| P69 | educated at | University of Barcelona | Q219615 |
| Harvard University | Q13371 | ||
| P108 | employer | National Cancer Institute | Q664846 |
| Massachusetts General Hospital | Q126412 | ||
| Strangeways Research Laboratory | Q21686504 | ||
| Harvard T.H. Chan School of Public Health | Q5676556 | ||
| Institute of Cancer Research | Q6039999 | ||
| P734 | family name | García | Q980636 |
| García | Q980636 | ||
| García | Q980636 | ||
| P735 | given name | Montserrat | Q601533 |
| Montserrat | Q601533 | ||
| P106 | occupation | researcher | Q1650915 |
| P1950 | second family name in Spanish name | Closas | Q109444674 |
| P21 | sex or gender | female | Q6581072 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q93025301 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
| Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
| Q28943348 | A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3 |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q28943367 | A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci |
| Q112727841 | A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer |
| Q34085748 | A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q46949960 | A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk |
| Q47704400 | A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. |
| Q37599352 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival |
| Q34414220 | A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q57026374 | Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium |
| Q33775440 | Active and passive cigarette smoking and the risk of endometrial cancer in Poland |
| Q57272084 | Adulthood Lifetime Physical Activity and Breast Cancer |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q37484995 | Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue |
| Q30779634 | Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases |
| Q39551156 | An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer |
| Q46949065 | An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer |
| Q38045344 | Analysis of epidemiologic studies of genetic effects and gene-environment interactions |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
| Q36201522 | Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study |
| Q36245614 | Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers |
| Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
| Q35082606 | Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q29616285 | Assessing the probability that a positive report is false: an approach for molecular epidemiology studies |
| Q33781177 | Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies |
| Q35593347 | Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study |
| Q90666760 | Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium |
| Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q27851709 | Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer |
| Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
| Q38794059 | Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast |
| Q37200998 | Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study |
| Q36885539 | Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism |
| Q34914663 | Association of COMT haplotypes and breast cancer risk in caucasian women |
| Q37217468 | Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q40513376 | Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors |
| Q56337548 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q112717774 | Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q36916852 | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes |
| Q64052468 | Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q35562912 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study |
| Q34158093 | Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression |
| Q39817047 | Bulky DNA adduct formation and risk of bladder cancer |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q33994241 | CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk |
| Q101237548 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis |
| Q24169697 | Characterization of large structural genetic mosaicism in human autosome |
| Q23914499 | Cigarette smoking and cancer risk: modeling total exposure and intensity |
| Q34031319 | Coffee consumption, genetic susceptibility and bladder cancer risk |
| Q27913969 | Collection of buccal cell DNA using treated cards |
| Q37657957 | Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q34736112 | Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer |
| Q36825511 | Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned |
| Q36944260 | Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer |
| Q28396581 | Common genetic variants in the 9p21 region and their associations with multiple tumours |
| Q35882541 | Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk |
| Q46897498 | Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status |
| Q44577591 | Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer |
| Q33829174 | Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
| Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
| Q62583503 | Comparative validation of breast cancer risk prediction models and projections for future risk stratification |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q52980715 | Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources. |
| Q39770549 | Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q37155532 | Consortium analysis of 7 candidate SNPs for ovarian cancer |
| Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
| Q44784782 | Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q37533025 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q30660858 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
| Q34608522 | DNA banking for epidemiologic studies: a review of current practices |
| Q35009790 | DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations |
| Q23916196 | Detectable clonal mosaicism and its relationship to aging and cancer |
| Q33802545 | Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers |
| Q30251440 | Developing and evaluating polygenic risk prediction models for stratified disease prevention |
| Q42509874 | Differences in risk factors for breast cancer molecular subtypes in a population-based study |
| Q37231038 | Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. |
| Q34020931 | Discovery and validation of methylation markers for endometrial cancer |
| Q112700572 | Discovery of structural deletions in breast cancer predisposition genes using whole genome sequencing data from > 2000 women of African-ancestry |
| Q57568597 | Does increased urination frequency protect against bladder cancer? |
| Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
| Q33824208 | ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study |
| Q33906376 | Effects of electron-beam irradiation on buccal-cell DNA. |
| Q34778269 | Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study |
| Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
| Q35914867 | Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q36611606 | Established breast cancer risk factors by clinically important tumour characteristics |
| Q51770859 | Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. |
| Q34133476 | Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer |
| Q51766497 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. |
| Q35910121 | Etiology of hormone receptor-defined breast cancer: a systematic review of the literature |
| Q21144976 | Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" |
| Q53332557 | Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q57568625 | Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q34157940 | Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q27908479 | Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome |
| Q34158088 | Fine mapping of 14q24.1 breast cancer susceptibility locus |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q57568610 | Food, nutrient and heterocyclic amine intake and the risk of bladder cancer |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q34520370 | GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis |
| Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
| Q38408978 | GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q57568634 | Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk |
| Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
| Q36903719 | Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q53349070 | Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. |
| Q53577804 | Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q37156413 | Genetic susceptibility loci for breast cancer by estrogen receptor status |
| Q41130542 | Genetic susceptibility to breast cancer |
| Q24624419 | Genetic susceptibility to distinct bladder cancer subphenotypes |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q46825192 | Genetic variation in CYP17 and endometrial cancer risk |
| Q35559023 | Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland |
| Q34038369 | Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis |
| Q53334287 | Genetic variation in TP53 and risk of breast cancer in a population-based case control study. |
| Q33298581 | Genetic variation in five genes important in telomere biology and risk for breast cancer |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q33599595 | Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis |
| Q37454788 | Genetic variation in the androgen receptor gene and endometrial cancer risk |
| Q57568620 | Genetic variation in the base excision repair pathway and bladder cancer risk |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q57272107 | Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk |
| Q51937498 | Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. |
| Q34203675 | Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q24289213 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q57551327 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
| Q29417050 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk |
| Q28659283 | Genome-wide association study identifies multiple loci associated with bladder cancer risk |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q28660394 | Genome-wide association study of endometrial cancer in E2C2 |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
| Q28943359 | Genome-wide interaction study of smoking and bladder cancer risk |
| Q37012918 | Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study |
| Q112716940 | Genomic and evolutionary classification of lung cancer in never smokers |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q34158129 | Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome |
| Q43875721 | Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases |
| Q34014453 | HSD17B1 genetic variants and hormone receptor-defined breast cancer |
| Q51802043 | Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
| Q37121271 | High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium |
| Q46925482 | Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study |
| Q33551425 | Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study |
| Q30437453 | Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
| Q50064953 | Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer. |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36754771 | Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q90091185 | Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q61226938 | Immune gene expression profiling reveals heterogeneity in luminal breast tumors |
| Q104468640 | Impact of Population Growth and Aging on Estimates of Excess U.S. Deaths During the COVID-19 Pandemic, March to August 2020 |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q40745717 | Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. |
| Q34575290 | Inherited variants in regulatory T cell genes and outcome of ovarian cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q57272091 | Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status |
| Q30910707 | Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients |
| Q53182487 | Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. |
| Q53594185 | Intrauterine environment and breast cancer risk in a population-based case-control study in Poland. |
| Q36643044 | Intrauterine environments and breast cancer risk: meta-analysis and systematic review |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q36003630 | Invited commentary: screening and the elusive etiology of prostate cancer |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q35022313 | LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer |
| Q37711685 | LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q33275297 | Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk |
| Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q34125066 | Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background |
| Q47915070 | Lessons Learned From Past Gene-Environment Interaction Successes |
| Q35088725 | Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study |
| Q36854277 | Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women |
| Q44832181 | Loss of antigenicity in stored sections of breast cancer tissue microarrays |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q35856276 | Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer |
| Q37197625 | Maximizing DNA yield for epidemiologic studies: no more buffy coats? |
| Q36944544 | Measurement of sex steroid hormones in breast adipocytes: methods and implications |
| Q79864140 | Measurement of urine pH for epidemiological studies on bladder cancer |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
| Q35156802 | MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q46762212 | Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms |
| Q47250468 | Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q39006395 | Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer |
| Q33739409 | Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom |
| Q36361883 | Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms |
| Q58546150 | Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues |
| Q24598972 | Molecular pathology in epidemiologic studies: a primer on key considerations |
| Q28393244 | Mosaic loss of chromosome Y is associated with common variation near TCL1A |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q34603354 | NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q34057961 | No association between FTO or HHEX and endometrial cancer risk |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q37378287 | Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium |
| Q51082413 | Occupation and breast cancer risk in Polish women: a population-based case-control study. |
| Q33937406 | Occupational exposure to organic solvents and breast cancer in women |
| Q35759885 | Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study |
| Q35802988 | Ovarian cancer risk associated with inherited inflammation-related variants |
| Q33699606 | Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q36184231 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q34486353 | Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q34008159 | Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade |
| Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
| Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
| Q34064069 | Performance of common genetic variants in breast-cancer risk models |
| Q35783067 | Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls |
| Q36831883 | Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q99609978 | Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast |
| Q33891803 | Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium |
| Q57250685 | Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses |
| Q37434877 | Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q57568614 | Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer |
| Q57025247 | Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype |
| Q28214623 | Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review |
| Q38045341 | Population-based study designs in molecular epidemiology |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q37487782 | Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q36614790 | Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis |
| Q37350137 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups |
| Q37531336 | Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland |
| Q34250104 | Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland |
| Q35223068 | Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q33257174 | Quantitation of DNA in buccal cell samples collected in epidemiological studies |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q52651950 | RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. |
| Q114182625 | Rare germline copy number variants (CNVs) and breast cancer risk |
| Q57272115 | Re: More data regarding the effects of passive smoking on breast cancer risk among younger women |
| Q34557167 | Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium |
| Q64110313 | Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study |
| Q37593548 | Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients |
| Q44183331 | Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women |
| Q34870700 | Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry |
| Q90259542 | Reply to 'Mosaic loss of chromosome Y in leukocytes matters' |
| Q46935184 | Reply: Study design and statistics in epidemiology of breast cancer. |
| Q89753406 | Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case–control study |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q36610421 | Reproductive risk factors for endometrial cancer among Polish women |
| Q57611127 | Response |
| Q42628372 | Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q43163251 | Searching for blood DNA methylation markers of breast cancer risk and early detection |
| Q34158134 | Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q37151786 | Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer |
| Q35809351 | Skewed X chromosome inactivation and early-onset breast cancer |
| Q51796129 | Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. |
| Q33593016 | Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies |
| Q35038651 | TGF-β signaling pathway and breast cancer susceptibility |
| Q57568595 | TGFB1andTGFBR1polymorphic variants in relationship to bladder cancer risk and prognosis |
| Q125589374 | TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study |
| Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| Q50690518 | Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. |
| Q44903190 | Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study |
| Q34372389 | The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease |
| Q35746371 | The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q33736182 | The impact of misclassification in case-control studies of gene-environment interactions. |
| Q28742979 | The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q34244301 | The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens |
| Q57272141 | Tobacco smoking,NAT2 acetylation genotype and breast cancer risk |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q115209628 | Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations |
| Q37157438 | Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q36977055 | Type I and II endometrial cancers: have they different risk factors? |
| Q35456563 | Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland |
| Q35020453 | Urinary pH, cigarette smoking and bladder cancer risk |
| Q28200507 | Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain |
| Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
| Q57272119 | Variation in breast cancer hormone receptor andHER2levels by etiologic factors: A population-based analysis |
| Q43829390 | Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. |
| Q34504966 | Well-done, grilled red meat increases the risk of colorectal adenomas. |
| Q51916590 | Whole genome amplification of buccal cytobrush DNA collected for molecular epidemiology studies. |
| Q45229605 | Whole genome prediction of bladder cancer risk with the Bayesian LASSO. |
| Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
| Q62089510 | Winners curse correction and variable thresholding improve performance of polygenic risk modeling based on summary-level data from genome-wide association studies |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
| Catalan (ca / Q7026) | Montserrat García-Closas | wikipedia |
| Montserrat García-Closas | wikipedia | |
| Montserrat García-Closas | wikipedia |
Search more.